ABLE: single-arm trial of nab-paclitaxel with ANTI-PD1 in advanced urothelial cancer.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Michigan, U-M Rogel Cancer Center, Michigan Medicine
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Celgene
OpenAlex ID: W3007495795
